-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Initiates Coverage On Parabilis Medicines with Buy Rating, Announces Price Target of $45

Benzinga·07/06/2026 10:29:15
Listen to the news
B of A Securities analyst Tazeen Ahmad initiates coverage on Parabilis Medicines (NASDAQ:PBLS) with a Buy rating and announces Price Target of $45.